Gene therapy in pediatric oncology

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Advances in understanding cancer molecular mechanisms and gene transfer into mammalian cells have spurred the development of gene therapy for cancer.
• Preclinical models have informed the design of gene transfer strategies now being evaluated in pediatric clinical trials.

Purpose of the Study:

• To review current gene transfer strategies for pediatric cancer treatment.
• To highlight the potential and challenges of gene therapy in pediatric oncology.

Main Methods:

• Utilizing marker genes to track cell origins in autologous bone marrow transplantation for pediatric cancers.
• Clinical testing of therapeutic genes, including immunostimulatory genes for enhanced antitumor immunity and drug sensitization genes for brain tumors.
• Evaluating strategies like drug resistance gene insertion, anti-oncogene therapy, and tumor suppressor gene replacement.

Main Results:

• Marker gene studies have yielded crucial information on bone marrow transplantation efficacy.
• Clinical trials are actively investigating the potential of various therapeutic genes, including those aimed at boosting immune response and sensitizing tumors to drugs.
• Promising strategies for adult cancers are being explored for pediatric applications.

Conclusions:

• Gene transfer presents a promising frontier for pediatric cancer therapy, with ongoing clinical evaluations of diverse strategies.
• Significant technical hurdles must be overcome to enhance the efficacy and accessibility of gene therapy for childhood cancers.
• Continued basic research in cancer biology and vector development is essential to fully realize the potential of gene therapy.